Follow-up after treatment for adrenal gland cancer

Follow-up after treatment is an important part of cancer care. Follow-up for adrenal gland cancer is often shared among your surgeon, endocrinologist (a doctor who specializes in diseases of the endocrine system) and family doctor. Your healthcare team will work with you to decide on follow-up care to meet your needs.

Don’t wait until your next scheduled appointment to report any new symptoms and symptoms that don’t go away. Tell your healthcare team if you have:

  • weight gain
  • muscle weakness or cramps
  • excessive hair growth on face, arms, chest and back in women
  • mood changes
  • headache
  • rapid heart beat
  • anxiety
  • pain in the abdomen or back
  • diarrhea

Adrenal gland cancer can come back (recur) at any time, so close follow-up is needed.

Schedule for follow-up visits

Follow-up visits for adrenal gland cancer are often scheduled as follows:

  • 2 to 6 weeks after surgery to check hormone levels
  • every 3 months for the first 2 or 3 years
  • every 6 months for the next 5 years

During follow-up visits

During a follow-up visit, your healthcare team will usually ask questions about the side effects of treatment and how you’re coping. Tests are often part of follow-up care. You may have:

  • a physical exam
  • blood chemistry tests to check hormone levels
  • urine tests to check hormone levels
  • imaging tests such as a CT scan, an MRI, a bone scan or a chest x-ray to check for metastases
  • an MIBG scan to check for pheochromocytoma tumours

If the cancer has come back, you and your healthcare team will discuss a plan for your treatment and care.

Questions to ask about follow-up

To make the decisions that are right for you, ask your healthcare team questions about follow-up.

Expert review and references

  • American Cancer Society . Adrenal Cancer . 2014 : https://www.cancer.org/.
  • Lirov R, Else T, Lerario AM, Hammer GD . Adrenal tumors. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 84:1195-1204.
  • Phan AT, Habbra MA, Gurbbs EG, Moran C . Adrenal neoplasms. Raghavan D, Blanke CD, Honson DH, et al (editors). Textbook of Uncommon Cancer. 4th ed. Wiley Blackwell; 2012: 3(10):163-187.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society